Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus

Detalles Bibliográficos
Autores principales: Dai, Huifang, Xu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344726/
https://www.ncbi.nlm.nih.gov/pubmed/35915432
http://dx.doi.org/10.1186/s12891-022-05707-w
_version_ 1784761280129662976
author Dai, Huifang
Xu, Jing
author_facet Dai, Huifang
Xu, Jing
author_sort Dai, Huifang
collection PubMed
description
format Online
Article
Text
id pubmed-9344726
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93447262022-08-03 Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus Dai, Huifang Xu, Jing BMC Musculoskelet Disord Correction BioMed Central 2022-08-01 /pmc/articles/PMC9344726/ /pubmed/35915432 http://dx.doi.org/10.1186/s12891-022-05707-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Dai, Huifang
Xu, Jing
Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
title Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
title_full Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
title_fullStr Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
title_full_unstemmed Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
title_short Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
title_sort correction: creatinine‑to‑cystatin c ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344726/
https://www.ncbi.nlm.nih.gov/pubmed/35915432
http://dx.doi.org/10.1186/s12891-022-05707-w
work_keys_str_mv AT daihuifang correctioncreatininetocystatincratioasamarkerofsarcopeniaforidentifyingosteoporosisinmalepatientswithtype2diabetesmellitus
AT xujing correctioncreatininetocystatincratioasamarkerofsarcopeniaforidentifyingosteoporosisinmalepatientswithtype2diabetesmellitus

Ejemplares similares